Advancing today’s therapies to enable healthier lives
We are a clinical stage biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases
Proprietary portfolio
Using our Arestat® technology platform, we are developing enhanced therapeutic medicines for the treatment of diabetes and obesity
Partnering
We are partnering with leading pharmaceutical and medtech companies to develop enhanced therapeutic medicines
Validated technology
A business underpinned by the world-leading Arestat® technology platform with a robust intellectual property portfolio
Latest News
-
9th December 2025
Arecor and Sequel Med Tech to host virtual fireside panel discussion
-
4th November 2025
Arecor Enhances IP Coverage for AT278 and Oral Delivery Technology
-
29th September 2025
Executive and Non-Executive Board Changes